Back
Drugs Made in America Acquisition Corp.
Blank Check Company
About
Drugs Made In America Acquisition, a blank check company focusing on the U.S. pharmaceutical sector.
The Fort Lauderdale, Florida-based company aims to raise $500 million by offering 50 million units at $10 each. Each unit will include one share of common stock and rights to one-tenth of a share. If the offering goes as planned, the company would achieve a market valuation of $706 million.
Drugs Made In America Acquisition is led by CEO and Executive Chair Lynn Stockwell, who is also the founder and Chair of Bright Green (Nasdaq: BGXX), and CFO Glenn Worman, a partner at SeatonHill Partners and CFO of Insight Acquisition (NYSE: INAQ). The company intends to target a pharmaceutical business within the United States.
Founded in 2024, Drugs Made In America Acquisition is based in Fort Lauderdale, Florida, and plans to list on the Nasdaq under the symbol DMAAU. EF Hutton will serve as the sole bookrunner for the deal.
Headquarters
1 East Broward Boulevard, Suite 700 Fort Lauderdale, FL 33301
Team
CEO and Executive Chair Lynn Stockwell, CFO Glenn Worman
Underwriters
Craft Capital Management LLC,
EF Hutton LLC
Calls within Tajikistan are free
Investments
Information
The information provided is for informational purposes only and should not be considered as an offer to buy or sell foreign currency, securities and/or other financial instruments. The information presented on this website is not an individual investment recommendation. Financial instruments or transactions mentioned in this section may not be suitable for you, may not correspond to your investment profile, financial situation, investment experience, knowledge, investment objectives, attitude to risk and profitability.
LLC "Exchange Broker" does not guarantee and does not promise future profitability of investments, does not guarantee the reliability of possible investments and the stability of possible income. Investment results in the past do not guarantee income in the future.
LLC "Exchange Broker" is not responsible for possible investor losses in the event of transactions and investments in financial instruments, and also does not guarantee the return, effectiveness and profitability of investments.
LLC "Exchange Broker" hereby informs that it operates in the securities market in accordance with the following professional participant licenses issued by the Ministry of Finance of the Republic of Tajikistan: depository activity No.010/25 dated 25.06.2025; brokerage activity No.007/25 dated 25.06.2025; dealer activity No.008/25 dated 25.06.2025 and securities management activity No.009/25 dated 25.06.2025, and also informs about the risk of a conflict of interest, including as a result of combining various types of professional activity in the securities market.